Sen. Sheldon Whitehouse Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Senator Sheldon Whitehouse sold shares of UnitedHealth Group worth between $15,001 and $50,000 on August 28th, as reported in a filing on September 3rd.
• UnitedHealth Group's quarterly earnings showed a net revenue of $111.62 billion, which slightly missed analysts' expectations, along with a reported EPS of $4.08.
• The company announced a quarterly dividend of $2.21 per share, yielding 2.9%, with the ex-dividend date set for September 15th.

Senator Sheldon Whitehouse (D-Rhode Island) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on September 03rd, the Senator disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on August 28th.

Senator Sheldon Whitehouse also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Kenvue NYSE: KVUE on 8/28/2025.
• Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 8/28/2025.
• Sold $15,001 - $50,000 in shares of Lam Research NASDAQ: LRCX on 8/28/2025.
• Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 7/7/2025.
• Sold $15,001 - $50,000 in shares of Analog Devices NASDAQ: ADI on 7/3/2025.

UnitedHealth Group Stock Performance

UNH stock traded up $2.10 during trading on Thursday, reaching $309.98. The company had a trading volume of 7,689,002 shares, compared to its average volume of 12,774,417. The company has a market cap of $280.74 billion, a price-to-earnings ratio of 13.43, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a 50-day simple moving average of $288.51 and a 200-day simple moving average of $377.17. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the business earned $6.80 earnings per share. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Wall Street Analyst Weigh In

UNH has been the subject of several recent research reports. Piper Sandler reduced their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Morgan Stanley dropped their target price on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a report on Wednesday, August 20th. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. TD Securities restated a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $353.71.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.28% of the company's stock.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently bought and sold shares of UNH. Norges Bank purchased a new stake in UnitedHealth Group during the 2nd quarter worth approximately $3,837,207,000. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Nuveen LLC acquired a new position in UnitedHealth Group during the 1st quarter worth $3,846,764,000. Vanguard Group Inc. raised its position in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Finally, Berkshire Hathaway Inc purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $1,572,193,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

About Senator Whitehouse

Sheldon Whitehouse (Democratic Party) is a member of the U.S. Senate from Rhode Island. He assumed office on January 3, 2007. His current term ends on January 3, 2031. Whitehouse (Democratic Party) ran for re-election to the U.S. Senate to represent Rhode Island. He won in the general election on November 5, 2024.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.